| abstract |
The present invention relates to novel organic compounds, to the process for synthesizing same and to the uses thereof, in particular in the field of cancer treatment. In particular, the present invention relates to novel anticancer compounds, in particular compounds capable of effectively inhibiting the mTOR (mammalian target of rapamycin) enzyme. The invention also relates to pharmaceutical or non-pharmaceutical compositions comprising said compounds. |